Employee Stock Option/ Share Scheme::ISSUANCE OF SHARES PURSUANT TO ENTERPRISE OPTION SCHEME
October 07, 2021 at 09:47 pm EDT
Share
Additional Listing Announcement /Subdivision of Shares
IHH HEALTHCARE BERHAD
1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
Types of corporate proposal
Details of corporate proposal
No. of shares issued under this corporate proposal
Issue price per share ($$)
Par Value($$) (if applicable)
No
Others
Issuance of shares pursuant to exercise of options under the 2015 Enterprise Option Scheme grant
15,500
Malaysian Ringgit (MYR) 5.6700
Latest issued share capital after the above corporate proposal in the following
Units
8,783,368,463
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 19,874,072,251.820
Listing Date
11 Oct 2021
2. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
Types of corporate proposal
Details of corporate proposal
No. of shares issued under this corporate proposal
Issue price per share ($$)
Par Value($$) (if applicable)
No
Others
Issuance of shares pursuant to exercise of options under the 2018 Enterprise Option Scheme grant
51,000
Malaysian Ringgit (MYR) 6.0200
Malaysian Ringgit (MYR)
Latest issued share capital after the above corporate proposal in the following
Units
8,783,419,463
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 19,874,379,271.820
Listing Date
11 Oct 2021
Announcement Info
Company Name
IHH HEALTHCARE BERHAD
Stock Name
IHH
Date Announced
08 Oct 2021
Category
Additional Listing Announcement /Subdivision of Shares
Reference Number
ALA-08102021-00001
Attachments
Original document
Permalink
Disclaimer
IHH Healthcare Berhad published this content on 08 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 October 2021 01:46:04 UTC.
IHH Healthcare Berhad is a Malaysia-based integrated healthcare provider. The Company's segments include Hospital and Healthcare, IMU Health, Labs, PLife REIT and Others. It operates its Hospital and Healthcare segment in Singapore, Malaysia, India, Greater China, Turkey and Europe and Southeast Asia. The IMU Health segment is engaged in providing educational services. The Labs segment provides diagnostic laboratory services. The PLife REIT segment is a real estate investment trust. Through its portfolio of brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway, the Company offers its patients comprehensive and personalized care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging, and rehabilitation. It provides day-to-day healthcare services through outpatient treatment, routine check-ups, and vaccinations. Its secondary care comprises specialist consultation, local surgeries, and others.